AVNS
HealthcareAvanos Medical, Inc.
$13.69+0.26 (+1.94%)
Prev Close
$13.43
Open
$13.67
High
$13.95
Low
$13.58
Volume
487.9K
Market Cap
$608.7M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Avanos Medical, Inc. (AVNS) has been mixed between buying and selling, with 1 insider purchase totaling $659.3K and 3 insider sales totaling $470.7K. The most recent insider transaction was by Holbrook Kerr (SVP, Chief Commercial Officer), who sold $165.0K worth of shares on Nov 18, 2025. Avanos Medical, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $608.7M.
Buys (12M)
1
$659.3K
Sells (12M)
3
$470.7K
Net Activity
Net Buyer
$188.6K
Active Insiders
4
last 12 mo
AVNS Price Chart
AVNS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 15,000 | $11.00 | $165.0K | 0 |
| Sep 5, 2025↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 345 | $12.66 | $4.4K | 0 |
| Aug 13, 2025↗ | BLACKFORD GARY | Director | Buy | 60,000 | $10.99 | $659.3K | 0 |
| May 13, 2025↗ | Greiner Michael | Former Interim CEO | Sell | 24,245 | $12.43 | $301.4K | 0 |
| Mar 6, 2025↗ | Greiner Michael | Interim CEO | Sell | 13,597 | $15.30 | $208.0K | 0 |
| Mar 6, 2025↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 13,064 | $15.28 | $199.6K | 0 |
| Mar 6, 2025↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 353 | $15.30 | $5.4K | 0 |
| Mar 6, 2025↗ | James Mojirade | SVP, General Counsel | Sell | 4,631 | $15.30 | $70.9K | 0 |
| Mar 6, 2025↗ | Woody Joseph Fralin | Insider | Sell | 32,076 | $15.30 | $490.8K | 0 |
| Mar 4, 2025↗ | Greiner Michael | Interim CEO | Sell | 10,690 | $15.13 | $161.7K | 0 |
| Mar 4, 2025↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 3,346 | $15.13 | $50.6K | 0 |
| Mar 4, 2025↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 71 | $15.13 | $1.1K | 0 |
| Mar 4, 2025↗ | James Mojirade | SVP, General Counsel | Sell | 4,704 | $15.13 | $71.2K | 0 |
| Mar 4, 2025↗ | Woody Joseph Fralin | Insider | Sell | 18,351 | $15.13 | $277.7K | 0 |
| Jul 22, 2024↗ | James Mojirade | SVP, General Counsel | Sell | 684 | $21.99 | $15.0K | 0 |
| Mar 18, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 9,005 | $19.09 | $171.9K | 0 |
| Mar 18, 2024↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 3,596 | $19.09 | $68.6K | 0 |
| Mar 18, 2024↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 33,765 | $19.09 | $644.6K | 0 |
| Mar 14, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 8,000 | $19.12 | $153.0K | 0 |
| Mar 11, 2024↗ | Shimer Julie Ann | Director | Buy | 500 | $19.85 | $9.9K | 0 |
| Mar 6, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 5,118 | $19.00 | $97.2K | 0 |
| Mar 6, 2024↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 2,618 | $19.00 | $49.7K | 0 |
| Mar 6, 2024↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 141 | $19.00 | $2.7K | 0 |
| Mar 6, 2024↗ | James Mojirade | SVP, General Counsel | Sell | 1,951 | $19.00 | $37.1K | 0 |
| Mar 6, 2024↗ | Varshney Sudhakar | SVP, Global Supply Chain | Sell | 1,394 | $19.00 | $26.5K | 0 |
| Mar 6, 2024↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 8,868 | $19.00 | $168.5K | 0 |
| Mar 5, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 4,991 | $18.76 | $93.6K | 0 |
| Mar 5, 2024↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 1,502 | $18.76 | $28.2K | 0 |
| Mar 5, 2024↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 32 | $18.76 | $600.32 | 0 |
| Mar 5, 2024↗ | James Mojirade | SVP, General Counsel | Sell | 2,190 | $18.76 | $41.1K | 0 |
| Mar 5, 2024↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 8,431 | $18.76 | $158.2K | 0 |
| Dec 11, 2023↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 113 | $21.15 | $2.4K | 0 |
| Oct 30, 2023↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 562 | $17.81 | $10.0K | 0 |
| Jul 20, 2023↗ | James Mojirade | SVP, General Counsel | Sell | 663 | $26.15 | $17.3K | 0 |
| May 8, 2023↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 14,710 | $23.97 | $352.6K | 0 |
| May 8, 2023↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 1,772 | $23.97 | $42.5K | 0 |
| May 8, 2023↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 57,256 | $23.97 | $1.37M | 0 |
| Mar 6, 2023↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 3,037 | $29.62 | $90.0K | 0 |
| Mar 6, 2023↗ | Haydon William David | SVP, GM Pain Franchise | Sell | 1,513 | $29.62 | $44.8K | 0 |
| Mar 6, 2023↗ | Holbrook Kerr | SVP, GM Chronic Care | Sell | 1,513 | $29.62 | $44.8K | 0 |
| Mar 6, 2023↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 32 | $29.62 | $947.84 | 0 |
| Mar 6, 2023↗ | James Mojirade | SVP, General Counsel | Sell | 2,111 | $29.62 | $62.5K | 0 |
| Mar 6, 2023↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 8,314 | $29.62 | $246.3K | 0 |
| Jan 3, 2023↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 4,726 | $27.06 | $127.9K | 0 |
| Nov 7, 2022↗ | Holbrook Kerr | SVP, GM Chronic Care | Sell | 615 | $22.75 | $14.0K | 0 |
| Sep 6, 2022↗ | Ball David Edward | SVP - Global Supply Chain | Sell | 3,347 | $23.87 | $79.9K | 0 |
| Jul 20, 2022↗ | James Mojirade | SVP, General Counsel | Sell | 663 | $27.41 | $18.2K | 0 |
| Jun 9, 2022↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 94 | $27.66 | $2.6K | 0 |
| May 9, 2022↗ | Holbrook Kerr | SVP, GM Chronic Care | Sell | 743 | $27.74 | $20.6K | 0 |
| May 9, 2022↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 40 | $27.74 | $1.1K | 0 |
| Dec 17, 2021↗ | Ball David Edward | SVP - Global Supply Chain | Sell | 1,411 | $31.22 | $44.1K | 0 |
| Sep 15, 2021↗ | OLEARY PATRICK J | Director | Buy | 5,000 | $31.63 | $158.1K | 0 |
| May 7, 2021↗ | Negro Renato | Vice President - Controller | Sell | 243 | $42.82 | $10.4K | 0 |
| May 3, 2021↗ | Negro Renato | Vice President - Controller | Sell | 188 | $43.22 | $8.1K | 0 |
AVNS Insider Buying Activity
The following table shows recent insider purchases of Avanos Medical, Inc. (AVNS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025↗ | BLACKFORD GARY | Director | Buy | 60,000 | $10.99 | $659.3K | 0 |
| Mar 11, 2024↗ | Shimer Julie Ann | Director | Buy | 500 | $19.85 | $9.9K | 0 |
| Sep 15, 2021↗ | OLEARY PATRICK J | Director | Buy | 5,000 | $31.63 | $158.1K | 0 |
AVNS Insider Selling Activity
The following table shows recent insider sales of Avanos Medical, Inc. (AVNS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 15,000 | $11.00 | $165.0K | 0 |
| Sep 5, 2025↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 345 | $12.66 | $4.4K | 0 |
| May 13, 2025↗ | Greiner Michael | Former Interim CEO | Sell | 24,245 | $12.43 | $301.4K | 0 |
| Mar 6, 2025↗ | Greiner Michael | Interim CEO | Sell | 13,597 | $15.30 | $208.0K | 0 |
| Mar 6, 2025↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 13,064 | $15.28 | $199.6K | 0 |
| Mar 6, 2025↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 353 | $15.30 | $5.4K | 0 |
| Mar 6, 2025↗ | James Mojirade | SVP, General Counsel | Sell | 4,631 | $15.30 | $70.9K | 0 |
| Mar 6, 2025↗ | Woody Joseph Fralin | Insider | Sell | 32,076 | $15.30 | $490.8K | 0 |
| Mar 4, 2025↗ | Greiner Michael | Interim CEO | Sell | 10,690 | $15.13 | $161.7K | 0 |
| Mar 4, 2025↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 3,346 | $15.13 | $50.6K | 0 |
| Mar 4, 2025↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 71 | $15.13 | $1.1K | 0 |
| Mar 4, 2025↗ | James Mojirade | SVP, General Counsel | Sell | 4,704 | $15.13 | $71.2K | 0 |
| Mar 4, 2025↗ | Woody Joseph Fralin | Insider | Sell | 18,351 | $15.13 | $277.7K | 0 |
| Jul 22, 2024↗ | James Mojirade | SVP, General Counsel | Sell | 684 | $21.99 | $15.0K | 0 |
| Mar 18, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 9,005 | $19.09 | $171.9K | 0 |
| Mar 18, 2024↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 3,596 | $19.09 | $68.6K | 0 |
| Mar 18, 2024↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 33,765 | $19.09 | $644.6K | 0 |
| Mar 14, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 8,000 | $19.12 | $153.0K | 0 |
| Mar 6, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 5,118 | $19.00 | $97.2K | 0 |
| Mar 6, 2024↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 2,618 | $19.00 | $49.7K | 0 |
| Mar 6, 2024↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 141 | $19.00 | $2.7K | 0 |
| Mar 6, 2024↗ | James Mojirade | SVP, General Counsel | Sell | 1,951 | $19.00 | $37.1K | 0 |
| Mar 6, 2024↗ | Varshney Sudhakar | SVP, Global Supply Chain | Sell | 1,394 | $19.00 | $26.5K | 0 |
| Mar 6, 2024↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 8,868 | $19.00 | $168.5K | 0 |
| Mar 5, 2024↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 4,991 | $18.76 | $93.6K | 0 |
| Mar 5, 2024↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 1,502 | $18.76 | $28.2K | 0 |
| Mar 5, 2024↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 32 | $18.76 | $600.32 | 0 |
| Mar 5, 2024↗ | James Mojirade | SVP, General Counsel | Sell | 2,190 | $18.76 | $41.1K | 0 |
| Mar 5, 2024↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 8,431 | $18.76 | $158.2K | 0 |
| Dec 11, 2023↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 113 | $21.15 | $2.4K | 0 |
| Oct 30, 2023↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 562 | $17.81 | $10.0K | 0 |
| Jul 20, 2023↗ | James Mojirade | SVP, General Counsel | Sell | 663 | $26.15 | $17.3K | 0 |
| May 8, 2023↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 14,710 | $23.97 | $352.6K | 0 |
| May 8, 2023↗ | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 1,772 | $23.97 | $42.5K | 0 |
| May 8, 2023↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 57,256 | $23.97 | $1.37M | 0 |
| Mar 6, 2023↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 3,037 | $29.62 | $90.0K | 0 |
| Mar 6, 2023↗ | Haydon William David | SVP, GM Pain Franchise | Sell | 1,513 | $29.62 | $44.8K | 0 |
| Mar 6, 2023↗ | Holbrook Kerr | SVP, GM Chronic Care | Sell | 1,513 | $29.62 | $44.8K | 0 |
| Mar 6, 2023↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 32 | $29.62 | $947.84 | 0 |
| Mar 6, 2023↗ | James Mojirade | SVP, General Counsel | Sell | 2,111 | $29.62 | $62.5K | 0 |
| Mar 6, 2023↗ | Woody Joseph Fralin | Chief Executive Officer | Sell | 8,314 | $29.62 | $246.3K | 0 |
| Jan 3, 2023↗ | Greiner Michael | SVP - Chief Financial Officer | Sell | 4,726 | $27.06 | $127.9K | 0 |
| Nov 7, 2022↗ | Holbrook Kerr | SVP, GM Chronic Care | Sell | 615 | $22.75 | $14.0K | 0 |
| Sep 6, 2022↗ | Ball David Edward | SVP - Global Supply Chain | Sell | 3,347 | $23.87 | $79.9K | 0 |
| Jul 20, 2022↗ | James Mojirade | SVP, General Counsel | Sell | 663 | $27.41 | $18.2K | 0 |
| Jun 9, 2022↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 94 | $27.66 | $2.6K | 0 |
| May 9, 2022↗ | Holbrook Kerr | SVP, GM Chronic Care | Sell | 743 | $27.74 | $20.6K | 0 |
| May 9, 2022↗ | Hurley John Joseph | Principal Accounting Officer | Sell | 40 | $27.74 | $1.1K | 0 |
| Dec 17, 2021↗ | Ball David Edward | SVP - Global Supply Chain | Sell | 1,411 | $31.22 | $44.1K | 0 |
| May 7, 2021↗ | Negro Renato | Vice President - Controller | Sell | 243 | $42.82 | $10.4K | 0 |
| May 3, 2021↗ | Negro Renato | Vice President - Controller | Sell | 188 | $43.22 | $8.1K | 0 |
AVNS Insiders
Similar Stocks to AVNS
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B